IN RE: UNIVERSAL HEALTH SERVICES, INC., DERIVATIVE LITIGATION

  1. January 26, 2022

    UHS Investors Get $2.5M Fees After 'Audacious' $5.7M Bid

    Shareholders who accused Universal Health Services Inc. of misleading them about an overbilling scheme and agreed to a settlement secured a $2.5 million attorney fee award on Wednesday, less than half of the $5.7 million request called "audacious" by the Fortune 500 company.

  2. November 30, 2021

    Universal Health Slams 'Audacious' Fee Bid In Investor Suit

    Universal Health Services Inc. and its officers and directors have urged a Pennsylvania federal judge not to grant an "audacious" bid for $5.7 million in attorney fees for shareholders who accused the company of misleading them about an overbilling scheme, saying the plaintiffs lost the case.

  3. August 19, 2019

    UHS Directors Escape Derivative Suit Over Billing Practices

    A Pennsylvania federal judge on Monday dismissed a derivative suit alleging Universal Health Services Inc. officers and directors misled investors about an overbilling scheme, saying the investors should have asked the UHS board to bring the litigation before they did.

  4. April 10, 2019

    UHS Must Face Claims It Held Patients Illegally, Investors Say

    Shareholders in a legal fight with Universal Health Services Inc. in Pennsylvania federal court have said the hospital operator can't shake claims that it exaggerated patients' risk of suicide in order to hold them involuntarily and collect insurance payments.

  5. December 11, 2018

    Pa. Judge Won't Stay Derivative UHS Overbilling Claims

    A Pennsylvania federal judge has shot down a bid to pause a cluster of shareholder lawsuits over alleged overbilling by United Health Services Inc. while both a related securities class action and an investigation into potential False Claims Act violations draw to a conclusion.

  6. May 15, 2017

    UHS Execs Over-Admitted Patients For Profit, Investor Says

    Universal Health Services' senior executives and directors have knowingly overlooked the hospital operator's over-admittance of patients and wrongly billed government agencies for the fees, artificially boosting the price of shares that executives and directors then sold at a profit, according to a derivative complaint filed Friday in Pennsylvania federal court.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!